I'd like to open a business account <a href=" http://www.grasmerehotel.com/conferences/ ">loan housing</a> But now the US Food and Drug Administration has voted that Glaxo's pulmonary disease treatment Anoro showed sufficient efficacy and safety to justify approval. The final decision is expected on 18 December. Analysts at JP Morgan said: